SCTX compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

SCTXScribe Therapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

SCTXScribe Therapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

SCTXScribe Therapeutics, Inc.

15.54▼−4.10%· post 17.02· delayed

Mkt cap$40.1MRevenue$2MQ2 FY26Revenue—

AMGNAmgen Inc

478.34▲+3.70%· post 479.98· delayed

After hoursNov 4 '26delayed

Mkt cap$249.4BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

After hoursNov 4 '26delayed

SCTXScribe Therapeutics, Inc.

AMGNAmgen Inc

15.54▼−4.10%post 17.02delayed

Price

478.34▲+3.70%post 479.98delayed

$40.1M

Mkt cap

$249.4B

Q2 FY26$2M

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

SCTX15.54▼−4.10%vsAMGN478.34▲+3.70%After hoursNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SCTX: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

SCTX, solidAMGN, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SCTX 5

BIIBBiogencustomer

SNYSanoficustomer

—Acuitas Therapeuticsunlistedsupplier

—The Regents of the University of Californiaunlistedsupplier

1 more · SCTX chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›